# mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Source: https://onco.cc/trials/nct06761027/  
OnCo record `nct06761027` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of anlotinib and sintilimab in pancreatic cancer, run by Fujian Provincial Hospital, now recruiting.

## Summary

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer is a phase 1/2, interventional study registered as NCT06761027 by Fujian Provincial Hospital, with a registry enrolment figure of 29 participants, started 2024-12-23 and due to reach its primary completion in 2027-03. Interventions recorded: Anlotinib combined with Sintilimab. Conditions listed: Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer. Primary outcome: Objective response rate, ORR. Pancreatic eligibility wording from the registry: "Patients with locally advanced or metastatic pancreatic cancer diagnosed by histology or cytology;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06761027
- Phase: 1/2
- Setting: mFOLFIRINOX Combined With Anlotinib and Sintilimab as First-Line Therapy for Locally Advanced or Metastatic Pancreatic Cancer: A Prospective, Single-arm, Multicenter, Phase Ib/II Clinical Study
- Sponsor: Fujian Provincial Hospital
- Enrolled: 29

## Sources

- ClinicalTrials.gov NCT06761027: https://clinicaltrials.gov/study/NCT06761027

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Anlotinib](https://onco.cc/drugs/anlotinib/), [Sintilimab](https://onco.cc/drugs/sintilimab/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06761027.json